Gene: XRCC4
Official Full Name: X-ray repair cross complementing 4provided by HGNC
Gene Summary: The protein encoded by this gene functions together with DNA ligase IV and the DNA-dependent protein kinase in the repair of DNA double-strand breaks. This protein plays a role in both non-homologous end joining and the completion of V(D)J recombination. Mutations in this gene can cause short stature, microcephaly, and endocrine dysfunction (SSMED). Alternate transcript variants such as NM_022406 are unlikely to be expressed in some individuals due to a polymorphism (rs1805377) in the last splice acceptor site. [provided by RefSeq, Oct 2019]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04954 | XRCC4 Knockout cell line (HeLa) | Human | XRCC4 | 1:3~1:6 | Negative | Online Inquiry |
KO04955 | XRCC4 Knockout cell line (HCT 116) | Human | XRCC4 | 1:2~1:4 | Negative | Online Inquiry |
KO04956 | XRCC4 Knockout cell line (HEK293) | Human | XRCC4 | 1:3~1:6 | Negative | Online Inquiry |
KO04957 | XRCC4 Knockout cell line (A549) | Human | XRCC4 | 1:3~1:4 | Negative | Online Inquiry |
XRCC4 Gene Knockout Cell Lines are specialized cell models that have been genetically modified to disrupt the expression of the XRCC4 gene, a critical component of the non-homologous end joining (NHEJ) DNA repair pathway. This pathway plays a vital role in maintaining genomic stability by repairing double-strand breaks in DNA, which, if left unrepaired, can lead to mutations, cancer, and other genomic disorders. The knockout of XRCC4 enables researchers to study the implications of impaired DNA repair mechanisms and the resultant effects on cell survival, proliferation, and genomic integrity.
These cell lines function by utilizing CRISPR-Cas9 technology for precise gene editing, effectively creating a targeted disruption of the XRCC4 gene. This allows scientists to investigate various aspects of DNA repair processes, including cellular responses to ionizing radiation, chemotherapy, and potential therapeutic interventions. The applications of XRCC4 knockout cell lines are extensive, serving as indispensable tools in cancer research, genetic studies, and drug discovery efforts.
One of the primary advantages of using XRCC4 Gene Knockout Cell Lines is the ability to conduct highly controlled experiments that mimic specific genetic deficiencies in vivo. This specificity offers researchers an unprecedented level of understanding regarding the cellular mechanisms behind DNA repair dysfunctions. Moreover, compared to traditional methods like RNA interference, gene knockout provides a more permanent and comprehensive assessment of gene function.
Researchers and clinicians will find XRCC4 Gene Knockout Cell Lines invaluable for their potential to advance our understanding of DNA repair pathways and contribute to the development of novel cancer therapies. By using these cell lines, users can better comprehend the molecular underpinnings of various diseases and enhance targeted treatment strategies.
With a commitment to accelerating scientific discovery, our company specializes in providing high-quality genetic models and experimental tools. We leverage cutting-edge technology and in-depth expertise in genetic engineering, ensuring that our biological products meet the rigorous needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.